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Background: Toll-like receptor 3 (TLR3) recognizes dou-
ble-stranded RNA (dsRNA) and induces inflammation. In this 
study we attempted to ascertain if there are endogenous 
host molecules controlling the production of cytokines and 
chemokines. Two candidates, ribosomal protein L19 and L22, 
were analyzed to determine if they influence cytokine pro-
duction followed by TLR3 activation. In this study we report 
that L19 acts upon production of IP-10 or IL-8 differently in 
glioblastoma cells. Methods: L19 or L22 was transfected into 
HEK293-TLR3, A549 or A172 cells. After treatment with sev-
eral inhibitors of NF-kB, PI3K, p38 or ERK, production of IL-8 
or IP-10 was measured by ELISA. siRNA was introduced to 
suppress expression of L19. After Vesicular stomatitis virus 
infection, viral multiplication was measured by western blot. 
Results: L19 increased ERK activation to produce IL-8. In 
A172 cells, in which TLR3 is expressed at endosomes, L19 
inhibited interferon regulatory factor 3 (IRF3) activation and 
IP-10 production to facilitate viral multiplication, whereas 
L19 inhibited viral multiplication in A549 cells bearing TLR3 
on their cell membrane. Conclusion: Our results suggest that 
L19 regulates TLR3 signaling, which is cell type specific and 
may be involved in pathogenesis of autoimmune diseases 
and chronic inflammatory diseases.
[Immune Network 2011;11(3):155-162]
INTRODUCTION
Toll-like receptor 3 (TLR3), the typical anti-viral pattern recog-
nition receptor (PRR), recognizes dsRNA and activates nuclear 
factor-kB (NF-kB), interferon regulatory factor 3 (IRF3), and 
AP-1. TLR3 generally mediates anti-viral immunity, however, 
in  some  infections,  cytokines  or  chemokines  produced  by 
TLR3 change the host immunological niche to facilitate viral 
replication.  Therefore,  there  is  some  debate  about  the  role 
of TLR3 in viral infection. For example, TLR3 binds to dsRNA 
of the West Nile virus (WNV), which is produced during viral 
replication.  When  TLR3  deficient  mice  are  infected  with 
WNV, the virus multiply and encephalomyelitis does not se-
verely progress. Pathological findings were less than control 
mice, in which the blood-brain barrier is broken after viral 
infection and TNF-α or IL-β is produced via TLR3 activation 
(1).  The  lung  is  another  organ  where  TLR3  is  abundantly 
expressed. Invasion of the influenza A virus increases TLR3 
expression  and  leads  to  acute  pneumonitis  (2).  In  TLR3 
knock-out mice, the survival time is longer than in wild type 
mice,  although  considerable  amount  of  virus  is  detected  in 
the lung. These two reports showed that lack of TLR3 inhibits 
an unfavorable immune response to the host by modulating 
activation  of  the  innate  immune  response  or  CD8
＋T  cells. 
Therefore, although the TLR3 immune response inhibits viral 
multiplication,  it  may  also  induce  harmful  and  pathological 
inflammation (3,4). TLR3 signaling controls pathological phe-
nomena by decreasing mucus secretion in respiratory syncy-
tial virus (RSV) infection rather than acting directly on inhibit-
ing  viral  multiplication.  When  TLR3  deficient  mice  are  in-
fected with RSV, T helper 2 (TH2) cytokines are induced and 
mucus secretion increases, which is the representative finding 
i n  R S V  i n f e c t i o n . T h e r e f o r e ,  t h e s e  d i v e r s e  T L R 3  i m m u n e  r e -
actions depend on virus type, the amount of virus, infection 
route,  target  cells  and  infection  time  (5,6).
    In  respect  to  pathogens,  several  viral  components  are 
known to regulate innate immunity. NS1 of the influenza A 
virus (7), E3 of the vaccinia virus (8), and VP39 of the ebola Role of Ribosomal Proteins in TLR3 Signaling
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virus (9) bind to viral dsRNA and interfere the binding with 
TLR3. NS3-4A (10) of the hepatitis C virus inhibits TLR3 sig-
naling by degrading Toll-interleukin 1 receptor domain-con-
taining  adapter  inducing  interferon-β (TRIF).
  The ribosome consists of a small 40S subunit and a large 
60S subunit. These subunits are composed of 4 RNA species 
and approximately 80 structurally distinct proteins. RPL19 is 
found in the large ribosomal subunit (60S) of eukaryotes and 
archaea. RPL19 consists of two small globular domains con-
nected by an extended segment. RPL19 is located towards the 
surface of the large subunit, with one exposed end involved 
in  forming  the  inter-subunit  bridge  with  the  small  subunit. 
The other exposed end is involved in forming the translocon 
binding site, along with L22, L23, L24, L29, and L31e subunits 
(11,12).
    EBER (Epstein-Barr virus encoded small RNA)-1 produced 
in  cells  infected  with  EBV  (Epstein-Barr  virus)  is  a  167  bp 
non-translated RNA and has a stable stem-loop. EBER inter-
acts with PKR (RNA dependent protein kinase) to inactivate 
PKR and further inhibits IFN-induced apoptosis of host cells. 
EBER binds to L22 through stem-loop III and IV. L22 and PKR 
compete  with  each  other  to  bind  to  the  same  region  of 
EBER-1.  When  EBV  infection  occurs,  L22  binds  to  EBER 
which blocks PKR activation and maintains the host anti-viral 
immune  response  (13,14).
    In this study we attempted to determine if there are endog-
enous host molecules controlling the production of cytokines 
and chemokines. Two candidates, ribosomal protein L19 and 
L22,  were  analyzed  to  determine  if they  influence cytokine 
production  followed  by  TLR3  activation.
MATERIALS AND METHODS
Reagents
The p38 MAPK inhibitor SB203580, JNK inhibitors (I, II), PI3K 
inhibitors (LY294002, Wortmannin), NF-κB inhibitor BAY11- 
7082  and  the  MEK1/2  inhibitor  UO126  were  obtained  from 
Calbiochem (San Diego, CA., USA) and each dissolved in di-
methyl sulfoxide to achieve a stock concentration of 20 mM. 
For western blot analysis, anti-IκB-α or anti-phospho- IκB-
α,  anti-IRF3  or  anti-phospho-IRF3,  anti-ERK  or  anti-phos-
pho-ERK,  anti-phospho-JNK,  anti-phospho-p38,  anti-  phos-
pho-AKT,  anti-phospho-PTEN,  anti-phospho-PDK1,  and  an-
ti-RIG-I  antibodies  were  all  purchased  from  Cell  Signaling 
Technology (Beverly, MA, USA). Anti-V5 and anti-VSV G anti-
body  were  purchased  from  Invitrogen.  For  secondary  anti-
bodies, goat anti-mouse IgG and goat anti-rabbit IgG (Jackson 
Immuno  Research,  Baltimore,  MD,  USA)  were  used.
Cell culture
HEK293-TLR3 cell lines were purchased from InvivoGen and 
were  then  maintained  and  subcultured  in  10%  fetal  bovine 
serum (FBS; Gibco BRL, Grand Island, NY, USA) -Dulbecco’s 
modified Eagle’s medium (DMEM; Gibco BRL, Grand Island, 
NY, USA) at 37
oC in 5% CO2. The cell culture medium con-
tained  10μg/ml  of  blasticidin  (InvivoGen,  San  Diego,  CA, 
USA)  as  selection  antibiotics.  The  human  glioblastoma  cell 
line  A172  was  obtained  from  ATCC  (CRL-1620)  and  main-
tained in minimal essential medium (MEM, Gibco BRL, Grand 
Island, NY, USA) supplemented with 10% FBS and penicillin 
and  streptomycin  (Gibco  BRL,  Grand  Island,  NY,  USA)  at 
37
oC  in  5%  CO2.  A 5 4 9  c e l l s  o r i g i n a t e d  f r o m  l u n g  e p i t h e l i a l 
carcinoma (CCL-185
TM, ATCC, Manassas, VA, USA) and were 
cultured  in  MEM  containing  10%  FBS,  penicillin  and 
streptomycin.
Transient transfection and luciferase reporter gene 
assay
Luciferase reporter gene assay was performed with p133-Luc 
(IL-8  promoter,  kindly  provided  by  Professor  Naofumi 
Mukaida,  Kanazawa  University,  Japan)  and  pISRE-Luc  plas-
mid (Stratagene, West Cedar Creek, TX, USA). HEK293- TLR3 
or  A172  cells  were  grown  in  24-well  plates  with  10% 
FBS-DMEM at 37
oC in 5% CO2. Cells were cotransfected with 
0.05  mg/ml  p133-Luc,  pISRE-Luc  plasmids,  and  pCMV-β- 
galactosidase  vectors  (Promega,  Madison,  WI,  USA)  using 
FuGENE 6 Reagent (Roche, Indianapolis, IN, USA). After 24 
hrs,  cells  were  stimulated  with  poly(I:C)  (10μg/ml) 
(InvivoGen, San Diego, CA, USA) for 6 hrs, and cell extracts 
were  prepared.  Luciferase  activity  was  measured  using  a 
Luciferase  Reporter  Assay  System  (Promega,  Madison,  WI, 
USA) and β-galactosidase activity was measured using O-ni-
trophenyl-β-D-galactopyranoside  (Sigma-Aldrich,  St.  Louis, 
MI, USA) as the substrate. Luciferase activity was normalized 
for  transfection  efficiency  with  β-galactosidase  activity.
ELISA
A172 cells transiently transfected with L19 or a control vector 
(pcDNA3.1/V5) were treated with poly(I:C) (25μg/ml). After 
the indicated treatment with poly(I:C), culture medium was 
collected to measure IP-10 or IL-8 production. IP-10 or IL-8 
in  the  culture  supernatant  was  quantified  using  commercial Role of Ribosomal Proteins in TLR3 Signaling
Eun-Jeong Yang, et al.
157 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 3 June 2011
Figure 1. Effect of L19 on poly(I:C)-induced activation of ISRE promoter and IP-10 production. (A) HEK293-TLR3 cells were transfected with
empty vectors or expression vectors for L19 together with ISRE (IRF3 promoter) reporter plasmids. 18 hrs after transfection, cells were treated 
with poly(I:C) (10μg/ml) for 6 hrs in the presence of 25μM chloroquine (inhibitor of endosome acidification) or no inhibitor. After poly(I:C)
treatment luciferase assays were performed. Luciferase activity is normalized to β-galactosidase activity; results are means±s.d. from three separate
transfections. (B) A172 cells were transfected with empty vectors or V5-tagged L19 plasmid. 18 hrs after transfection, cells were stimulated with 
poly(I:C) (25μg/ml) in the presence or absence 25μM chloroquine for 8 or 24 hrs and thensupernatants were measured by ELISA for IP-10
production. Values represent the mean±S.E. of triplicate samples.
specific  ELISA  kits  (BD  Biosciences,  Franklin  Lakes,  New 
Jersey,  USA)  according  to  the  manufacturer’s  instructions. 
The  experiments  were  performed  in  triplicate. 
Western blot analysis
For  transient  transfection,  HEK293  or  A172  cells  (∼1×10
6) 
were transfected with L19 plasmids for 24 hrs. The transfected 
cells were lysed in 300μl of lysis buffer [20 mMTris, pH 7.5, 
150  mM  NaCl,  1%  Triton,  1mM  ethylenediaminetetraacetic 
acid (EDTA), 10μg/ml aprotinin, 10μg/ml leupeptin, 1 mM 
phenylmethylsulfonyl  fluoride].
    Total protein from either HEK293 or A172 cells transfected 
with L19 or control plasmids were separated with 10∼12% 
SDS-PAGE and transferred to nitrocellulose membranes. The 
blots were blocked in PBS-0.1%Tween 20 (PBST) containing 
5% non-fat milk and incubated with appropriate primary anti-
bodies at a dilution of 1：1,000. After three washes in PBST, 
peroxidase-conjugated  secondary  antibodies  were  incubated 
at a dilution of 1：5,000, washed three times with PBST and 
developed with an ECL system (GE Healthcare, Buckingham-
shire,  UK).
RNAi assay
Stealth
TMsiRNAs  were  obtained  from  Invitrogen.  Invitrogen 
supplied the sequences of the L19 siRNA and Stealth
TMRNAi 
negative control duplexes. Stealth
TMsiRNA is chemically modi-
fied  dsRNA  that  was  developed  to  overcome  the  limitation 
of  traditional  siRNA.  Stealth
TMRNAi  negative  control  duplex 
does  not  induce  the  interferon-mediated  stress  response 
pathway. The targeted sequence of L19 Stealth
TMsiRNA was 
5’- C U U  G G A  U A A  A G U  C U U  G A U  G A U  C U C C - 3 ’. 
HEK293/L19 cells transfected with the indicated siRNAs were 
then stimulated with poly(I:C) (20μg/ml) and activation of 
IRF3, and NF-κB, and protein levels of L19 were measured 
by  western  blot.
Vesicular stomatitis virus infection
Vesicular stomatitis virus (VSV, Indiana serotype, Mudd-Sum-
m m e r s  s t r a i n )  w a s  p r o p a g a t e d  i n  V e r o  c e l l s .  A f r i c a n  g r e e n  
monkey  kidney  epithelial  Vero  cells  were  maintained  in 
DMEM supplemented with 10% FBS. The viral titer was moni-
t o r e d  b y  a  p l a q u e  a s s a y  u s i n g  V e r o  c e l l s .  A 5 4 9  c e l l s  w e r e  
transfected  with  either  V5-tagged  L19  genes,  L22,  or  mock 
vectors. Cells were grown to 80∼90% confluence for 24 hrs 
and then infected with 1 MOI of VSV for 6 hrs in serum free 
medium.Role of Ribosomal Proteins in TLR3 Signaling
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Figure 2. Effect of L19 on poly(I:C)-induced activation of IL-8 promoter and IL-8 production. (A) A172 cells were transfected with empty vectors 
or expression vectors for L19 together with p133-Luc (IL-8 promoter) reporter plasmids. 18 hrs after transfection, cells were treated with poly(I:C)
(25μg/ml) for 6 hrs. After poly(I:C) treatment luciferase assays were performed. Luciferase activity is normalized to β-galactosidase activity; results
are means±s.d. from three separate transfections. (B) A172 cells were transfected with empty vectors or V5-tagged L19 plasmid. 18 hrs after 
transfection, cells were stimulated with poly(I:C) (25μg/ml) in the presence or absence 25μM chloroquine (inhibitor of endosome acidification)
for 6 or 24 hrs and then supernatants were measured by ELISA for IL-8. Values represent the mean±S.E. of triplicate samples.
RESULTS
Effect of L19 on induction of IP-10 and IL-8 followed by 
poly(I:C) administration
To assess the effect of L19 on the production of IRF3 depend-
ent chemokines and IP-10, ISRE promoter activity, and NF-κB 
o r  E R K  d e p e n d e n t  I L - 8  p r o d u c t i o n  w a s  e v a l u a t e d .  F i r s t ,  
HEK293 cells bearing TLR3 (HEK293/TLR3) were transfected 
with L19. Then 25μg/ml of poly(I:C) was administrated for 
6 hrs with or without chloroquine. As a result, ISRE activity 
decreased according to the transfected amount of L19 (Fig. 
1 A ) .  A 1 7 2  c e l l s ,  g l i o b l a s t o m a  c e l l s  e x p r e s s i n g  T L R 3 ,  w e r e  
transfected with L19 and treated with poly(I:C). After the in-
dicated  time,  culture  supernatants  were  harvested  and  the 
amount of IP-10 and IL-8 produced was measured by ELISA. 
Production of IP-10 or IL-8 changed in a L19 dose-dependent 
manner at only later time points (24 and 16 hrs after poly(I:C) 
treatment, respectively)  but not  at  early  time points  (8  and 
6  hrs  after  poly(I:C)  treatment,  respectively)  (Figs.  1B  and 
2A).  IL-8  promoter  activity  increased  dependently  with  the 
L19 dose (Fig. 2B). These results suggest that TLR3 signaling 
is  influenced  by  L19.
Effect of L19 on phosphorylation of NF-κB or IRF-3
Using cells over-expressing or lacking L19, immunoblotting of 
IκBα and IRF3 was performed. In HEK293 cells over-ex-
pressing  L19,  IκBα  was  phosphorylated  30  min  after 
poly(I:C) stimulation, which started early when compared to 
the control vector (Fig. 3A). When the expression of L19 was 
inhibited by siRNA, IRF3 activation increased, however activa-
tion of IκBα decreased slightly (Fig. 3B). These results sug-
gest that inhibition of IP-10 produciton by L19, elicits strong 
activation  of  the  TLR3-TRIF-NF-kB  pathway  to  compensate 
decreased  IRF3  activation  and  further  decreased  production 
of IP-10. A similar phenomenon was reported in a prior study 
demonstrating that the TRIF-dependent pathway is activated 
when  the  MyD88  dependent  pathway  is  inhibited.
Identification of signaling molecules or transcription 
factors participating in production of IP-10 or IL-8
Several  inhibitors  including  JNKI,  JNKII,  SB203580,  U0126, 
BAY11-7082, LY294002, and wortmannin were used to further 
detail  the  important  pathways  to  produce  IP-10  and  IL-8. 
Inhibitors  were  pretreated  and p o l y ( I : C )  w a s  a d m i n i s t r a t e d . 
ELISA  revealed  that  IP-10  was  decreased  by  either  the  p38 
inhibitor (SB203580), PI3K inhibitor (LY294002, wortmannin), 
or NF-κB inhibitor (BAY11-7082) (Fig. 4A). IL-8 production 
was inhibited most effectively by treatment with ERK inhibitor 
(U0126).Additionally, NF-kB inhibitor (BAY11-7082) and PI3K 
inhibitor  (LY294002)  blocked  the  signaling  to  produce  IL-8 Role of Ribosomal Proteins in TLR3 Signaling
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Figure 4. PI3 kinase plays differential roles in the production of 
TLR3-mediated IP-10 and IL-8. A172 cells were incubated with 
medium alone or with poly(I:C) (10μg/ml) for 18 hrs in the absence
or presence of various pharmacological inhibitors at the indicated 
concentrations: JNK I or II, SB203580, U0126, BAY11-7082, LY294002
and Wortmannin. Each inhibitor was added 45 min before poly(I:C)
stimulation. After treatment with poly(I:C), supernatants were measur-
ed by ELISA for IP-10 production (A) and IL-8 production (B). Values
represent the mean±S.E. of triplicate samples.
Figure 3. Effect of L19 on activation of IRF3 or IκBα in TLR3 signal-
ing. (A) HEK293 cells grown in 60mm plates were transfected with
control (pcDNA3.1) or V5-tagged L19. 48 hrs after transfection, cells
were stimulated with 20μg/ml poly(I:C) for the indicated time. 
Phosphorylated IκBα (p-IκBα) and total IκBαwere determined by
western blotting using anti-p-IκBα (Ser32) and anti-IκBα anti-
bodies. The expression level of L19 in the cell lysates was analyzed 
with anti-V5 antibody. To confirm equal loading, membranes were 
re-probed with anti-α-tubulin antibody. (B) siRNA oligo targeting L19 
or negative control were transfected into L19 expressing HEK293 
(HEK293-L19) cells to silence the expression of L19. 48 hrs after 
transfection, cells were stimulated without or with 20μg/ml of poly
(I:C) for the indicated time. Total cell lysates analyzed by immuno-
blotting with anti-phospho-IRF3 (Ser396) or anti-IRF-3 antibody, 
anti-p-IκBα (Ser32) or anti-IκBα antibodies. The efficiency of L19 
RNAi was confirmed by immunoblotting with anti-V5 (L19) antibody.
(Fig. 4A). On the contrary, PI3K inhibitor (wortmannin) in-
duced  IL-8  production  (Fig.  4B).
Effect of L19 on ERK phosphorylation
As shown above, L19 has an inhibitory effect on IP-10 pro-
duction but an stimulatory effect on IL-8 production in A172 
cells.  We  then  attempted  to  identify  the  molecules  respon-
sible for IL-8 induction in cooperation with L19. A172 cells 
were transfected with L19 and then pretreated with LY294002 
and wortmannin. Activation of ERK, IKBα, JNK, p38, PDK1, 
Akt,  and  PTEN  were  then  assessed  after  poly(I:C)  stimula-
tion. Results showed that LY294002 inhibited activation of all 
the tested signaling molecules, whereas the decreased phos-
phorylation of ERK, NF-κB, PDK1, and PTEN by wortmannin 
was recovered by transfection with L19 in a dose-dependent 
manner  (Fig.  5A).We  also  assessed  the  phosphorylation  of 
E R K ,  J N K ,  A k t ,  a n d  P D K  f r o m  1 - 1 2  h r s  a f t e r  p o l y ( I : C )  
stimulation.  Phosphorylation  of  ERK  increased  with  trans-
fection of L19 in a dose-dependent manner at 2 hrs (Fig. 5B) 
and at 12 hrs (Fig. 5C) after poly(I:C) treatment. However, 
activation of JNK and PDK decreased with transfection of L19 
in a dose-dependent manner at 2 hrs after poly(I:C) treatment 
and phosphorylation of Akt increased at 1 hr after poly(I:C) 
treatment (Fig. 5B). These results suggest that L19 increases 
the  activation  of  ERK,  however  decreases  the  activation  of 
JNK  and  PDK.
Effect of L19 on anti-viral response in association 
with L22
Next we demonstrated the effect of L19 on VSV infection us-
ing A549 cells originating from lung epithelial cells, where the 
major expression site of TLR3 is at the cell membrane. RIG 
expression  was  also  inhibited  by  introducing  shRNA  into 
these cells. VSV multiplication was then evaluated by measur-
ing levels of viral G protein 24 hrs after initial viral infection. Role of Ribosomal Proteins in TLR3 Signaling
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Figure 5. Effects of PI3K inhibitors together with L19 on TLR-mediated activation of intracellular signaling molecules. (A) A172 cells were transfected
with empty vectors or V5-tagged L19 plasmid. 18 hrs after transfection, cells were stimulated with poly(I:C) (25μg/ml) in the presence or absence
LY294002 (LY, 20μM) and wortmannin (Wort, 5μM) for 20 hrs and then total cell lysates analyzed by immunoblotting with anti-phospho-ERK,
-IκBα, -JNK, -p38, -PDK1, -Akt, -PTEN antibodies. To confirm equal loading, membranes were re-probed with anti-α-tubulin antibody. (B) A172
cells were transfected with empty vectors or V5-tagged L19 plasmid. 20 hrs after transfection, cells were stimulated with poly(I:C) (25μg/ml)
for 60 or 120 min (B) and 12 hrs (C) and then total cell lysates analyzed by immunoblotting with anti-phospho-ERK, -JNK, -PDK1, -Akt antibodies.
The expression level of exogenous or endogenous L19 in the cell lysates were analyzed with anti-L19 monoclonal antibody. To confirm equal
loading, membranes were re-probed with anti-α-tubulin antibody.
Figure 6. Effect of L19 together with L22 in anti-viral immunity. A549
cells treated with RIG-I siRNAs were transfected with L19 or L22. 24
hrs after transfection, cells were infected with 1MOI VSV for 6 hrs 
and then extracts from VSV-infected cells were analyzed by western
blotting with antibodies against G protein (VSV), RIG-I, phospho-IRF3
(Ser396) and phospho-PKR (Thr451).
When RIG-1 and L22 were transfected together, viral multi-
plication  was  inhibited  and  RIG-1  activation  was  induced 
(Fig.  6).
    When  L19  were  transfected  in  A549  cells,  viral  multi-
plication was inhibited (Fig. 6). Especially L19 induced RIG-1 
expression and activation of IRF3 (Fig. 6). This finding is con-
trary to the results acquired with A172 cells and suggests that 
the effect of L19 varies with different cell types and the local-
ization  site  of  TLR3.
DISCUSSION
Recently the influence of TLR members has been reported in 
various inflammatory and immune disorders such as sepsis, 
asthma, atherosclerosis, Alzheimer’s disease, and rheumatoid 
arthritis (15,16). With certain genetic predispositions, TLR sig-
naling leads to overt symptoms in various autoimmune dis-
eases,  for  example,  systemic  lupus  erythematosus,  multiple 
sclerosis,  and  inflammatory  bowel  disease  (17).  Therefore, 
TLR molecules and related signaling have become potential 
therapeutic  targets  and  are  under  evaluation.
    Here we report that L19 modulates TLR3 signaling induced 
by poly(I:C). In A172 cells, a glioblastoma cell line, over-ex-
pression  of  L19  inhibits  production  of  IP-10  and  increases 
production of IL-8. Generally TLR3 activation following viral 
infection increases production of TNF-α, IL-1β, IL-6, IP-10, Role of Ribosomal Proteins in TLR3 Signaling
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and IL-8 to eliminate pathogens (18). However, this response 
is cell type specific. For example, TLR3 activation increased 
the production of TNF-α, RANTES, and MIP-1α in murine 
fetalskin-derived  cultured  mast  cells  (FSMC),  whereas  it  in-
duced production of IL-6 and IL-12, not chemokines, in mi-
croglial cells (19). In another experiment, respiratory syncytial 
virus  (RSV)  was  infected  into  two  different  cells,  MRC-5 
(human lung fibroblasts) and A549 (lung epithelial cells) cells, 
respectively.  In  this  particular  study,  chemokines  such  as 
IP-10,  CCL5  and  IL-8  were  induced  and  the  expression  of 
TLR3  increased  in  A549  cells.  However,  TLR3  knock-down 
using RNAi decreased production of IP-10 and CCL5, whereas 
IL-8 was either not affected or rather increased in MRC5 cells 
(20). All these reports suggest that signaling induced by TLR3 
differs  with  cell  types.
    TLR3  signaling  induces  activation  of  IKK,  ERK,  and  JNK 
and  further  produces  TNF-α,  IL-1β,  IL-6,  and  IL-8.  The 
pharmacological  inhibitor  of  JNK,  SP600125,  blocked  pro-
duction of IP-10 and IL-8. The ERK inhibitor study suggests 
ERK is responsible for inhibiting IL-8, but not IP-10 (21,22). 
PI3K is necessary for full activation of IRF3, an important tran-
scription  factor  involved  in  the  production  of  IFN-β and 
IP-10,  whereas  it  inhibits  activation  of  GSK-3β and  ERK. 
During TLR3 signaling PI3K contributes to IP-10 production 
by activating IRF3, however it inactivates GSK-3β and ERK 
to decrease IL-8 production (23). All of these studies demon-
strate that the end products of TLR3 signaling are affected by 
major signaling pathways and that each responds in a differ-
ent  manner.
    First,  to  identify  which  signaling  molecules  were  respon-
sible for IP-10 and IL-8 production in association with L19, 
inhibitors were used against JNKI, JNKII, EKR, p38, PI3K, and 
NF-kB in A172 cells. As a result, we found that through acti-
vation  of  both  NF-κB  and  ERK,  L19  further  enhanced  the 
increase in production of IL-8 by poly(I:C). When L19 was 
over-expressed, the phosphorylation of IκB-α and ERK in-
c r e a s e d  w i t h  L 1 9  i n  a  d o s e  d e p e n d e n t  m a n n e r .  M o r e o v e r ,  
knock-down of L19 lead to decreased phosphorylation of 
IκB-α at an early stage after poly(I:C) treatment. The find-
ing that IRF3-dependent IP-10 production was inhibited by ei-
ther LY294002 or wortmannin suggests that the PI3K pathway 
is affected by L19 involvement. Furthermore, phosphorylation 
of IRF3 increased with knock-down of L19. These results sug-
gest  that  introduction  of  L19  into  cells  inhibits  the  TLR3- 
TRIF-PI3K-IRF3 pathway and the production of IP-10. At the 
same time, L19 induces activation of the TLR3-TRIF-NF-κB 
and ERK pathway and production of IL-8. Although LY294002 
and wortmannin belong to the same family of PI3K inhibitors, 
the underlying mechanism of action is different. Wortmannin 
inhibits myosin light chain kinases and PI3K-related protein 
kinases, whereas LY294002 is the effective inhibitor for casein 
kinase2 (24). This explains our discordant result showing that 
TLR3-mediated cytokine production increases with wortman-
nin  treatment,  but  decreases  with  LY294002.
    Next, A549 cells, lung epithelial cells, were infected with 
VSV. Introduction of L19 inhibited VSV replication. Another 
r i b o s o m a l  p r o t e i n ,  L 2 2 ,  a l s o  b l o c k e d  V S V  m u l t i p l i c a t i o n .  
These results are contrary to those found with A172 cells, in 
which  L19  induced  inactivation  of  the  TLR3-TRIF-PI3K-IRF3 
pathway and decreased the production of IP-10. These find-
ings demonstrate that the effect of L19 on TLR3 signaling is 
cell  type-specific  and  dependent  upon  the  localization  of 
TLR3  in  cells.
    Therefore,  with  these  results  we  suggest  that  L19  could 
have a pivotal role in viral multiplication dependent upon cell 
type and may be involved in the pathogenesis of autoimmune 
diseases  and  chronic  inflammatory  diseases.
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